恢复ATF3作为治疗性结肠炎的潜在策略:西申药丸研究的含义
Yutong Jin1, Xuetao Dong2, Weilong Zhong3
1School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, PR China; Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China.
西申药丸 (SSP) 显示了治疗性结肠炎 (UC) 的潜力,通过减少通过激活转录因子3 (ATF3) 介导的炎症和中性粒细胞细胞外陷 (NET) 的形成. 这些发现表明SSP是UC的有前途的辅助疗法.
科学领域:
- 胃肠道学和免疫学
- 分子生物学和治疗学
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病,对中度至重度病例的治疗选择有限.
- 激活转录因子3 (ATF3) 在炎症反应中起作用.
- 西申药丸 (SSP) 正在研究其在UC的治疗潜力.
研究的目的:
- 评估Sishen Pill (SSP) 在性结肠炎 (UC) 的治疗潜力.
- 研究激活转录因子3 (ATF3) 在SSP治疗效果中的作用.
- 探索SSP改善结肠炎的机制,重点关注中性细胞外细胞陷 (NET) 和炎症途径.
主要方法:
- 从UC患者和健康对照组收集了结肠活检样本.
- 建立了用SSP治疗的酸 (DSS) 诱导的小鼠结肠炎模型.
- 通过体重,结肠长度和炎症标志物评估治疗疗效.
- 利用转录基因分析,西式涂抹,免疫光和Luminex测试来评估SSP对ATF3信号和NETs形成的影响.
主要成果:
- 在UC患者和DSS诱导的大肠炎小鼠中观察到ATF3表达的减少和NETs形成的增加.
- SSP治疗上调了ATF3,缓解了结肠炎症状 (体重减轻,结肠缩短,组织病理损伤),并减少了炎症性细胞因子.
- SSP抑制了参与NETs形成,TNF和CXCL1/CXCR2信号通路的关键基因和蛋白质,证明了ATF3依赖的机制.
结论:
- 通过抑制NETs的形成,减少炎症,并通过ATF3调制抑制CXCL1/CXCR2介导的炎症,SSP可以改善小鼠的结肠炎.
- 这些发现支持SSP作为UC的潜在辅助疗法.
- 向ATF3为未来的UC治疗提供了一个有希望的治疗策略.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents


